Axsome Therapeutics (AXSM) Misses Q1 EPS by 3c

Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($0.31), $0.03 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Endava CFO placed on leave amid accounting probe
• Credo Technology shares rise on analyst support and conference comments